Pre-Analytical Conditions in Non-Invasive Prenatal Testing of Cell-Free Fetal RHD

Research output: Contribution to journal › Journal article › Research

Standard

Pre-Analytical Conditions in Non-Invasive Prenatal Testing of Cell-Free Fetal RHD. / Clausen, Frederik Banch; Jakobsen, Tanja Roien; Rieneck, Klaus; Krog, Grethe Risum; Nielsen, Leif Kofoed; Tabor, Ann; Dziegiel, Morten Hanefeld.

In: PloS one, Vol. 8, No. 10, 2013, p. e76990.

Research output: Contribution to journal › Journal article › Research

Harvard

Clausen, FB, Jakobsen, TR, Rieneck, K, Krog, GR, Nielsen, LK, Tabor, A & Dziegiel, MH 2013, 'Pre-Analytical Conditions in Non-Invasive Prenatal Testing of Cell-Free Fetal RHD', PloS one, vol. 8, no. 10, pp. e76990. https://doi.org/10.1371/journal.pone.0076990

APA

Clausen, F. B., Jakobsen, T. R., Rieneck, K., Krog, G. R., Nielsen, L. K., Tabor, A., & Dziegiel, M. H. (2013). Pre-Analytical Conditions in Non-Invasive Prenatal Testing of Cell-Free Fetal RHD. PloS one, 8(10), e76990. https://doi.org/10.1371/journal.pone.0076990

Vancouver

Clausen FB, Jakobsen TR, Rieneck K, Krog GR, Nielsen LK, Tabor A et al. Pre-Analytical Conditions in Non-Invasive Prenatal Testing of Cell-Free Fetal RHD. PloS one. 2013;8(10):e76990. https://doi.org/10.1371/journal.pone.0076990

Author

Clausen, Frederik Banch ; Jakobsen, Tanja Roien ; Rieneck, Klaus ; Krog, Grethe Risum ; Nielsen, Leif Kofoed ; Tabor, Ann ; Dziegiel, Morten Hanefeld. / Pre-Analytical Conditions in Non-Invasive Prenatal Testing of Cell-Free Fetal RHD. In: PloS one. 2013 ; Vol. 8, No. 10. pp. e76990.

Bibtex

@article{cdf3098000244f93aa16ee2a7d30e28e,
title = "Pre-Analytical Conditions in Non-Invasive Prenatal Testing of Cell-Free Fetal RHD",
abstract = "Non-invasive prenatal testing of cell-free fetal DNA (cffDNA) in maternal plasma can predict the fetal RhD type in D negative pregnant women. In Denmark, routine antenatal screening for the fetal RhD gene (RHD) directs the administration of antenatal anti-D prophylaxis only to women who carry an RhD positive fetus. Prophylaxis reduces the risk of immunization that may lead to hemolytic disease of the fetus and the newborn. The reliability of predicting the fetal RhD type depends on pre-analytical factors and assay sensitivity. We evaluated the testing setup in the Capital Region of Denmark, based on data from routine antenatal RHD screening.",
author = "Clausen, {Frederik Banch} and Jakobsen, {Tanja Roien} and Klaus Rieneck and Krog, {Grethe Risum} and Nielsen, {Leif Kofoed} and Ann Tabor and Dziegiel, {Morten Hanefeld}",
year = "2013",
doi = "10.1371/journal.pone.0076990",
language = "English",
volume = "8",
pages = "e76990",
journal = "PLoS ONE",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "10",

}

RIS

TY - JOUR

T1 - Pre-Analytical Conditions in Non-Invasive Prenatal Testing of Cell-Free Fetal RHD

AU - Clausen, Frederik Banch

AU - Jakobsen, Tanja Roien

AU - Rieneck, Klaus

AU - Krog, Grethe Risum

AU - Nielsen, Leif Kofoed

AU - Tabor, Ann

AU - Dziegiel, Morten Hanefeld

PY - 2013

Y1 - 2013

N2 - Non-invasive prenatal testing of cell-free fetal DNA (cffDNA) in maternal plasma can predict the fetal RhD type in D negative pregnant women. In Denmark, routine antenatal screening for the fetal RhD gene (RHD) directs the administration of antenatal anti-D prophylaxis only to women who carry an RhD positive fetus. Prophylaxis reduces the risk of immunization that may lead to hemolytic disease of the fetus and the newborn. The reliability of predicting the fetal RhD type depends on pre-analytical factors and assay sensitivity. We evaluated the testing setup in the Capital Region of Denmark, based on data from routine antenatal RHD screening.

AB - Non-invasive prenatal testing of cell-free fetal DNA (cffDNA) in maternal plasma can predict the fetal RhD type in D negative pregnant women. In Denmark, routine antenatal screening for the fetal RhD gene (RHD) directs the administration of antenatal anti-D prophylaxis only to women who carry an RhD positive fetus. Prophylaxis reduces the risk of immunization that may lead to hemolytic disease of the fetus and the newborn. The reliability of predicting the fetal RhD type depends on pre-analytical factors and assay sensitivity. We evaluated the testing setup in the Capital Region of Denmark, based on data from routine antenatal RHD screening.

U2 - 10.1371/journal.pone.0076990

DO - 10.1371/journal.pone.0076990

M3 - Journal article

C2 - 24204719

VL - 8

SP - e76990

JO - PLoS ONE

JF - PLoS ONE

SN - 1932-6203

IS - 10

ER -

ID: 94618407